Latest Bayer Group Stories
New CONTOUR(®) NEXT EZ Strip and Meter Combination is accurate and easy to use TORONTO, Jan. 9, 2013 /CNW/ - A new, accurate and easy-to-use blood glucose monitoring system is now available for diabetes patients in Canada. The CONTOUR(®) NEXT EZ meter combines easy-to-use features and next-generation accuracy with Bayer's new CONTOUR(®) NEXT test strip to help patients better manage their diabetes. "Bayer's new CONTOUR(®) NEXT EZ system is especially accurate in low blood...
MORRISTOWN, N.J., Dec. 5, 2012 /PRNewswire/ -- Bayer HealthCare, in partnership with Mom Central Consulting, announced findings from a recent survey indicating that three-quarters (76 percent) of moms whose children suffer from the skin condition eczema do not feel knowledgeable about the condition. Further, while almost all had discussed it with their children's doctor, nearly 40 percent were unsatisfied with those conversations. To view the multimedia assets associated with this...
Former fighter pilot, Jim "Murph" Murphy, delivered his nationally acclaimed Flawless Execution® model to more than 60 members of Bayer Healthcare Pharmaceuticals leadership team in Lisbon, Portugal Atlanta, GA (PRWEB) December 03, 2012 Jim Murphy, founder of the global management training firm, Afterburner, was featured as the guest speaker at Bayer Healthcare’s annual leadership meeting in Portugal this month. The concept behind Flawless Execution® combines...
-- First publication of the global Phase III CORRECT and GRID study data of the oral multi-kinase inhibitor regorafenib TORONTO, Nov. 27, 2012 /CNW/ - Bayer HealthCare today announced that the results of two pivotal Phase III studies for regorafenib were published online in the journal The Lancet ahead of a future print publication. Data from the CORRECT (Metastatic Colorectal cancer treated with regorafenib or placebo after failure of standard therapy)...
-- Coronary or Peripheral Artery Disease patients carry significant risk of fatal or debilitating myocardial infarction and stroke -- Rivaroxaban is the first novel oral anticoagulant currently under investigation in this high risk patient population -- 20,000-patient study will be conducted in collaboration with Canada's Population Health Research Institute (PHRI), representing one of the largest...
HILDEN, Germany, October 25, 2012 /PRNewswire/ -- - QIAGEN and Bayer HealthCare signed collaboration agreement aimed at advancing both companies positions in personalized medicine - The programs pair QIAGEN companion diagnostic solutions with innovative targeted therapies for patients with solid tumors developed by Bayer HealthCare - Agreement provides framework for further collaboration projects QIAGEN (NASDAQ: QGEN;...
TARRYTOWN, N.Y., Sept. 28, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that EYLEA(®) (aflibercept) Injection has received approval for the treatment of patients with neovascular age-related macular degeneration (wet AMD) from the Japanese Ministry of Health, Labour and Welfare (MHLW). In Japan, EYLEA treatment is initiated with one 2 milligram (mg) intravitreal injection per month for three consecutive months (treatment initiation)....
TARRYTOWN, N.Y., Sept. 21, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA(®) (aflibercept) Injection has been recommended for approval by the European Committee for Medicinal Products for Human Use (CHMP) for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD). The decision of the European Commission on approval is expected in the fourth quarter of 2012. "We are pleased with the positive...
MORRISTOWN, N.J., Sept. 4, 2012 /PRNewswire/ -- Bayer HealthCare's Consumer Care Division announced today the introduction of Bayer®( )Migraine Formula, an over-the-counter (OTC) medication designed to relieve migraine pain and accompanying symptoms - nausea, phonophobia (sound sensitivity) and photophobia (light sensitivity). The powerful triple action formula of aspirin, acetaminophen and caffeine aims to target and alleviate tough migraine pain fast and effectively. (Logo:...
TARRYTOWN, N.Y., June 7, 2012 /PRNewswire/ -- Bayer Radiology & Interventional announced the introduction of the Certegra® Workstation, an informatics-driven, touch?screen hub that enables time savings and improved patient care through a powerful suite of CT Contrast Dose Management(TM) applications and a new P3T® 2.0 operating environment. The new Workstation will be presented at the annual meeting of the Society for Imaging Informatics in Medicine (SIIM) 2012 June 7 - 12...
